Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?
European Heart Journal – Cardio-Oncology · 2026
DOI: 10.1093/ehjco/aabag006 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal – Cardio-Oncology, 2026. Verfasst von Adithya K Yadalam und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adithya K Yadalam, MD, MSc, Janghee Woo, MD, PhD, Sagar A Patel, MD, MSc, Anant Mandawat, MD; Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?, E
Zitieren
APA
Yadalam, A. K., Woo, J., Patel, S. A., & Mandawat, A. (2026). Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?. European Heart Journal – Cardio-Oncology. https://doi.org/10.1093/ehjco/aabag006
Vancouver
Yadalam AK, Woo J, Patel SA, Mandawat A. Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?. European Heart Journal – Cardio-Oncology. 2026. doi:10.1093/ehjco/aabag006
BibTeX
@article{Yadalam2026,
author = {Yadalam, Adithya K and Woo, Janghee and Patel, Sagar A and Mandawat, Anant},
title = {Statin Use in CHIP–ASCVD Research: Bias, Biology, or Both?},
journal = {European Heart Journal – Cardio-Oncology},
year = {2026},
doi = {10.1093/ehjco/aabag006}
}
EUVIMED